HighRes Biosolutions and Novo Nordisk partner to transform drug discovery in automated Lab of the Future
HighRes Biosolutions and Novo Nordisk A/S today announced that they will collaborate to design a state-of-the-art robotic platform for high-throughput biologics engineering and characterisation. The integration of a multi-system robotics platform with sophisticated software control architecture will enable a digital transformation and accelerated discovery for Novo Nordisk’s peptide and large molecule therapeutics research.
“In order to maintain our leadership within biologics engineering we are investing in a fully automated and digital design platform. This investment is linked to our build-up in AI and advanced analytics and demonstrates Novo Nordisk’s commitment as a world leading biologics research company,” said Lars Fogh Iversen, senior vice president, Global Research Technologies, Novo Nordisk.
The platform will comprise several highly automated and integrated cells for production, characterisation and functional analysis of thousands of biologic compounds every month. Its scope covers the full range from small synthetic peptides to recombinantly expressed large proteins and will also include chemical modification of the molecules. The ambition is to build a system that is fully integrated with a modern data infrastructure and the data science and machine learning capabilities in Novo Nordisk.
Ira Hoffman, CEO of HighRes Biosolutions, said: “We are very excited to be working with Novo Nordisk on their Lab of the Future. We believe that the combination of our capabilities, products and vision make us the ideal partner for their digital transformation.”
About Novo Nordisk
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases. Headquartered in Denmark, Novo Nordisk employs approximately 42,200 people in 80 countries and markets its products in more than 170 countries. For more information, visit novonordisk.com , Facebook , Twitter , LinkedIn , YouTube .
About HighRes Biosolutions
HighRes Biosolutions improves human health through life science robotics. The company designs and builds innovative laboratory automation systems, dynamic scheduling software, and lab automation instruments that accelerate and streamline discovery. HighRes offers highly flexible, modular solutions that provide its clients with the ability to scale and reconfigure their automation equipment as their assays or technology changes. Visit www.highresbio.com or follow HighResBio on LinkedIn .
For further information please contact: firstname.lastname@example.org
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
DEVEXPERTS27.5.2020 08:02:07 CEST | Press release
Devexperts Launches DXtrade as a SaaS Trading Platform for FX/CFD Brokers
CA-VERIMATRIX26.5.2020 17:47:11 CEST | Press release
Verimatrix Wins TV Technology’s Best of Show for VCAS 5 for DVB
TX-MARY-KAY26.5.2020 17:34:11 CEST | Press release
Mary Kay Unveils Groundbreaking Research During Skin of Color Society Virtual Program
NY-JEFFERIES26.5.2020 17:19:10 CEST | Press release
Jefferies to Hold Global Coronavirus Relief Charity Day Dedicated to the Memory of Peg Broadbent on May 27th
RI-NORDSON-EFD26.5.2020 16:28:08 CEST | Press release
New Automated Optical Inspection from Nordson EFD Verifies Fluid Deposit Placement and Accuracy
LARSEN-&-TOUBRO-INFOTECH26.5.2020 16:15:08 CEST | Press release
LTI Wins 2020 SAP® Pinnacle Award as the Industry Innovation Partner of the Year
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom